Cargando…
A Novel PHD2/VHL-mediated Regulation of YAP1 Contributes to VEGF Expression and Angiogenesis
The transcriptional coactivator YAP1 is the major oncogenic component of the Hippo signaling pathway and contributes to the genesis and progression of various tumors, including non–small cell lung cancer (NSCLC). YAP1 levels are regulated by the canonical Hippo kinases, MST1/2 and LATS1/2, which mod...
Autores principales: | Bora-Singhal, Namrata, Saha, Biswarup, Mohankumar, Durairaj, Padmanabhan, Jaya, Coppola, Domenico, Chellappan, Srikumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9351435/ https://www.ncbi.nlm.nih.gov/pubmed/35937460 http://dx.doi.org/10.1158/2767-9764.CRC-21-0084 |
Ejemplares similares
-
Novel HDAC11 inhibitors suppress lung adenocarcinoma stem cell self-renewal and overcome drug resistance by suppressing Sox2
por: Bora-Singhal, Namrata, et al.
Publicado: (2020) -
Regulation of Sox2 and stemness by nicotine and electronic-cigarettes in non-small cell lung cancer
por: Schaal, Courtney M, et al.
Publicado: (2018) -
Inhibitors Targeting CDK9 Show High Efficacy against Osimertinib and AMG510 Resistant Lung Adenocarcinoma Cells
por: Padmanabhan, Jaya, et al.
Publicado: (2021) -
EGFR/Src/Akt signaling modulates Sox2 expression and self-renewal of stem-like side-population cells in non-small cell lung cancer
por: Singh, Sandeep, et al.
Publicado: (2012) -
Fendiline inhibits proliferation and invasion of pancreatic cancer cells by interfering with ADAM10 activation and β-catenin signaling
por: Woods, Neha, et al.
Publicado: (2015)